Trademark: 79260490
Word
NIOBRICE
Status
Registered
Status Code
700
Status Date
Tuesday, March 8, 2022
Serial Number
79260490
Registration Number
6661707
Registration Date
Tuesday, March 8, 2022
Mark Type
4000
Filing Date
Monday, April 8, 2019
Published for Opposition
Tuesday, December 21, 2021

Trademark Owner History
Novartis AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Jul 17, 2022
Notification Processed By Ib
Jun 23, 2022
Final Disposition Notice Sent To Ib
Jun 23, 2022
Final Disposition Processed
Apr 7, 2022
Grant Of Protection Created, To Be Sent To Ib
Mar 8, 2022
Registered-Principal Register
Dec 21, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 21, 2021
Published For Opposition
Dec 1, 2021
Notification Of Possible Opposition Sent To Ib
Dec 1, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 1, 2021
Notification Of Notice Of Publication E-Mailed
Nov 17, 2021
Correction From Ib Entered - Attorney Review Required
Oct 6, 2021
Reg. Cancelled - Restored To Pendency
Jul 1, 2021
Assigned To Petition Staff
Jun 15, 2021
Request To Cancel Inadvertently Issued Registration Received
Apr 27, 2021
Case Assigned To Post Registration Paralegal
Apr 27, 2021
Reinstated
Apr 27, 2021
Case Assigned To Post Registration Paralegal
Apr 24, 2021
Correction Transaction Received From Ib
Nov 2, 2019
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Nov 2, 2019
Death Of International Registration
Oct 22, 2019
Registered-Principal Register
Aug 13, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 13, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 6, 2019
Published For Opposition
Jul 17, 2019
Notice Of Publication
Jul 1, 2019
Approved For Pub - Principal Register
Jun 28, 2019
Application Filing Receipt Mailed
Jun 24, 2019
Assigned To Examiner
Jun 24, 2019
New Application Office Supplied Data Entered In Tram
Jun 17, 2019
Limitation From Original Application Entered
Jun 6, 2019
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24